SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab gets USFDA approval for Buspirone Hydrochloride Tablets

26 Aug 2014 Evaluate

Strides Arcolab has received approval from the United States Food & Drug Administration (USFDA) for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg. Buspirone Tablets are used for the treatment of anxiety disorders and the short-term relief of the symptoms of anxiety.

The US market for generic Buspirone Tablets is around $65 million. The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed directly by Strides in the US Market.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×